Skip to main content
. 2017 Apr 3;43(11):1613–1625. doi: 10.1007/s00134-017-4766-4

Fig. 3.

Fig. 3

Incremental cost and effectiveness of the molecular test when compared to standard workup: cost effectiveness plane for incremental costs and difference in 24-h documentation for neutropenic patients and patients with severe sepsis